# @pennmedicine on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/DF8l6IiRmUv
- **Gondola URL:** https://gondola.cc/posts/26601567-pennmedicine-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/4aaed68295.jpg
- **Posted:** 2025-02-11T20:57:21.000+00:00
- **Account Owner:** Penn Medicine (@PennMedicine) — https://gondola.cc/PennMedicine

## Caption

Last fall, 57-year-old Curt Krouse became the first Penn Medicine patient outside a clinical trial to receive the first FDA-approved gene therapy for adults with hemophilia B—with the promise of curing his rare bleeding disorder.

“It is hard to explain the feeling,” Krouse said. “[Now] I bang my arm or scratch my leg and instead of infusing, I just watch the affected area clot normally. It’s like a science fiction movie, but it’s real.”

Link in bio for the full story. 

#hemophilia #hemophiliab #genetherapy

## Stats

- **Views:** 0
- **Likes:** 790
- **Shares:** 0
- **Comments:** 5

## Tags

hemophiliab, genetherapy, hemophilia

---
Copyright (c) Gondola